Argus Research Maintains Buy on Xylem, Raises Price Target to $165
Portfolio Pulse from Benzinga Newsdesk
Argus Research has maintained its Buy rating on Xylem (NYSE:XYL) and raised the price target from $146 to $165, indicating a positive outlook for the company's stock.
May 29, 2024 | 2:46 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Argus Research has maintained its Buy rating on Xylem and raised the price target from $146 to $165, suggesting a positive outlook for the company's stock.
The raised price target from $146 to $165 by Argus Research indicates increased confidence in Xylem's future performance. This positive analyst rating is likely to boost investor sentiment and drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100